Biotech · Private company
R-Pharm International, LLC
Track this companyFree. Adds R-Pharm International, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Adalimumab 40mg q2wPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Concomitant treatmentPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- OlokizumabPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Olokizumab 64 mg SC q2wPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Olokizumab 64 mg SC q4wPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Olokizumab 64mg q2wPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Olokizumab 64mg q4wPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid ArthritisPHASE3 · COMPLETED · started Jul 4, 2017ClinicalTrials.gov NCT03120949 · fetched Nov 12, 2026
- Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active DiseasePHASE3 · COMPLETED · started Jan 25, 2017ClinicalTrials.gov NCT02760433 · fetched Nov 12, 2026
- Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active DiseasePHASE3 · COMPLETED · started Jun 6, 2016ClinicalTrials.gov NCT02760407 · fetched Nov 12, 2026